Home
Matthew T. Wiley, Chief Commercial Officer: Definium Therapeutics DFTX Sell · Filed 09/29
Trade details
- Type
- Insider sale
- Amount
- $113,257.29
- Shares · price
- 3,097 sh · $36.57 a share
- Held after
- 359,036 sh
- Trade date
- 26/09/25
- Filed
- 26/09/29
- Days to filing
- 4 days
Sold 0.9% of holdings
- Share of holding sold
- 0.9%
Definium Therapeutics trades, last 26 weeks
What else happened in Definium Therapeutics around then
Filed or reported within 30 days of the trade day · 08/26~10/25Matthew T. Wiley's recent trades
- Matthew T. Wiley
Planned saleDefinium Therapeutics
Planned saleDefinium Therapeutics
DFTX
$113.8K
3,097 sh
$113.8K
Filed 09/25
Traded 09/25
- Matthew T. Wiley
Sell10b5-1 planDefinium Therapeutics
Sell10b5-1 planDefinium Therapeutics
DFTX
$129.1K
2,867 sh
$129.1K
Filed 06/26
Traded 06/25
- Matthew T. Wiley
Planned saleDefinium Therapeutics
Planned saleDefinium Therapeutics
DFTX
$120.8K
2,867 sh
$120.8K
Filed 06/25
Traded 06/25
- Matthew T. Wiley
Sell10b5-1 planBioXcel Therapeutics
Sell10b5-1 planBioXcel Therapeutics
BTAIQ
$3,450
6,272 sh
$3,450
Filed 24/10/03
Traded 24/10/03
- Matthew T. Wiley
Sell10b5-1 planBioXcel Therapeutics
Sell10b5-1 planBioXcel Therapeutics
BTAIQ
$148
215 sh
$148
Filed 24/09/17
Traded 24/09/16
